Dr. Charles N. Bruce-Tagoe, MD

Dr. Bruce-Tagoe practices at Hartford Healthcare Medical Group Specialists in Stratford, Connecticut.

Dr. Bruce-Tagoe's NPI, 1417122946, was assigned on April 25, 2008. Dr. Bruce-Tagoe holds Connecticut license 47946.

Dr. Bruce-Tagoe's primary practice is Hartford Healthcare Medical Group Specialists, at 3272 Main St, Stratford, CT 06614 in Greater Bridgeport County. The practice phone is (860) 246-2071.

Dr. Bruce-Tagoe's primary practice is Hartford Healthcare Medical Group Specialists in Stratford, Connecticut. Dr. Bruce-Tagoe is also affiliated with Bridgeport Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Bruce-Tagoe to 1 more hospital, 4 home health agencies, 2 medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bruce-Tagoe practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bruce-Tagoe's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bruce-Tagoe is licensed in Connecticut.

CMS data shows 498 Medicare services from Dr. Bruce-Tagoe across 6 procedure codes in 2024, for 206 Medicare patients. Medicare paid $43,286 for them. Every service was in an office.

CMS counts 206 Medicare patients who saw Dr. Bruce-Tagoe in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bruce-Tagoe's median patient age at 62, with 48% women.

In 2024, Dr. Bruce-Tagoe wrote 9,185 Medicare Part D claims for 680 patients. 85% of them were for generic drugs. CMS names the drug for 8,247 of them, across 131 drugs with 11 or more claims each, at $794,289 in total drug cost. In 2023, CMS named 8,008 claims across 138 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bruce-Tagoe for performance year 2024, reported as part of a group. Dr. Bruce-Tagoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bruce-Tagoe as offering telehealth.

CMS Open Payments shows 52 general payments to Dr. Bruce-Tagoe from 16 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $282.